The FDA is cracking down on CBD products.The agency said Curaleaf claims its products can help with conditions such as Alzheimer's disease and cancer but alleges those statements are not true.Cannabidiol is a compound found in marijuana but it doesn't cause a high. It's widely marketed in oils, lotions and foods but, recently, the Food and Drug Administration issued a warning letter to Curaleaf, a leading marijuana company, for making unproven heath claims about CBD.The FDA said claims could delay medical attention for serious conditions, such as cancer. WESH 2 News spoke with Dr. Todd Husty, the emergency medical services director for Seminole County."You can't make a claim for curing something. They have to stop short of that, so some of the claims that have been made about CBD oil is that it actually cures things, but it's not proven," Husty said.The FDA told Curaleaf that it was illegally selling CBD with unsubstantiated claims."I think the real problem with that, as a doctor, is that people might stop other, better treatments that are known to work. These are not known to work. I would certainly not take CBD oil instead of a real live treatment," Husty said.Curaleaf Hemp, the company's hemp-based CBD product line, immediately began an extensive review of its website and social media platforms to remove all statements that the FDA identified as noncompliant."Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace," Curaleaf's CEO Joseph Lusardi said. "We care deeply about our customers and making a difference in our industry."

The FDA is cracking down on CBD products.

The agency said Curaleaf claims its products can help with conditions such as Alzheimer's disease and cancer but alleges those statements are not true.

Advertisement Related Content ‘Waste away’ to relaxation with CBD spa treatments at Central Florida resort

Cannabidiol is a compound found in marijuana but it doesn't cause a high. It's widely marketed in oils, lotions and foods but, recently, the Food and Drug Administration issued a warning letter to Curaleaf, a leading marijuana company, for making unproven heath claims about CBD.

The FDA said claims could delay medical attention for serious conditions, such as cancer.

WESH 2 News spoke with Dr. Todd Husty, the emergency medical services director for Seminole County.

"You can't make a claim for curing something. They have to stop short of that, so some of the claims that have been made about CBD oil is that it actually cures things, but it's not proven," Husty said.

The FDA told Curaleaf that it was illegally selling CBD with unsubstantiated claims.

"I think the real problem with that, as a doctor, is that people might stop other, better treatments that are known to work. These are not known to work. I would certainly not take CBD oil instead of a real live treatment," Husty said.

Curaleaf Hemp, the company's hemp-based CBD product line, immediately began an extensive review of its website and social media platforms to remove all statements that the FDA identified as noncompliant.

"Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace," Curaleaf's CEO Joseph Lusardi said. "We care deeply about our customers and making a difference in our industry."